IL6 and COVID-19: Given the fact that IL-6 is a key mediator of the “cytokine storm” that leads to acute respiratory distress syndrome (ARDS) and multi-organ dysfunction in severe COVID-19 [14], it can be assumed that such a distribution of tRF types may be due to the condition the patient underwent.